Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Granules India

Granules India

BSE: 532482|NSE: GRANULES|ISIN: INE101D01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 18, 16:00
88.35
-0.7 (-0.79%)
VOLUME 278,447
LIVE
NSE
Jun 18, 15:57
88.60
-0.65 (-0.73%)
VOLUME 3,312,862
News on Granules India
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Granules India; target of Rs 97: Geojit

3.27 pm | 08 Jun 2018 |  Source: Moneycontrol.com

Geojit is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 97 in its research report dated May 30, 2018....

Buy Granules India; target of Rs 150: Centrum Research

4.33 pm | 06 Jun 2018 |  Source: Moneycontrol.com

Centrum Research is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 150 in its research report dated May 3...

Stocks in the news: NCC, Infosys, Idea, M&M, Fortis, Sudarshan Chemical, Mindtree

7.47 am | 01 Jun 2018 |  Source: Moneycontrol.com

Stocks in the news: NCC, Idea, M&M, Fortis Healthcare, Sudarshan Chemical...

Buy Granules India; target of Rs 115: HDFC Securities

4.38 pm | 31 May 2018 |  Source: Moneycontrol.com

HDFC Securities is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 115 in its research report dated May 25...

Granules India's US arm launches generic Methergine tablets in US market

7.39 pm | 30 May 2018 |  Source: PTI

Granules India Ltd today said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership with...

Granules India touches 52-week low on 55% dip in Q4 profit

9.36 am | 25 May 2018 |  Source: Moneycontrol.com

On Thursday, the company has reported 55 percent fall in its Q4FY18 consolidated net profit at Rs 20.4 crore on the back of weak operational performan...

Granules India reports 55% fall in Q4 net profit at Rs 20.4 crore

4.58 pm | 24 May 2018 |  Source: Moneycontrol.com

The company board recommended a final dividend of 25 paise per share of face value of Re 1 each for the financial year 2017-18....

Granules gets USFDA nod for postpartum haemorrhage prevention drug

10.58 am | 17 May 2018 |  Source: PTI

In a filing to BSE, Granules India said "the U S Food and Drug Administration (USFDA) has approved its abbreviated new drug applications (ANDA) for Me...

Granules India rises 2% on USFDA approval for Methylergonovine tablets

9.23 am | 17 May 2018 |  Source: Moneycontrol.com

Methylergonovine is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum haemorrhage....

Granules receives USFDA approval for generic Methylergonovine tablets

8.57 am | 17 May 2018 |  Source: Moneycontrol.com

Granules India announced that the USFDA has approved its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets....

Granules India gains 4% on Establishment Inspection Report from USFDA for Jeedimetla unit

1.30 pm | 16 May 2018 |  Source: Moneycontrol.com

Jeedimetla facility manufactures active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates (PFIs)....

Granules India Q4 PAT seen up 3% YoY to Rs. 37.4 cr: KR Choksey

3.31 pm | 23 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 21.8 percent Y-o-Y (up 5.4 percent Q-o-Q) to Rs. 432.7 crore, according to KR Choksey....

Granules India Q4 PAT may dip 13.3% YoY to Rs. 40 cr: HDFC Securities

1.47 pm | 20 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 16.5 percent Y-o-Y (up 0.7 percent Q-o-Q) to Rs. 410 crore, according to HDFC Securities....

1 2
Quick Links for Granules India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.